Recommendation for use of diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate, and hepatitis B vaccine in infants

• Main Authors: Hye-Kyung Cho (Author), Su Eun Park (Author), Yae-Jean Kim (Author), Dae Sun Jo (Author), Yun-Kyung Kim (Author), Byung-Wook Eun (Author), Taek-Jin Lee (Author), Jina Lee (Author), Hyunju Lee (Author), Ki Hwan Kim (Author), Eun Young Cho (Author), Jong Gyun Ahn (Author), Eun Hwa Choi (Author)
• Format: Book
• Published: The Korean Pediatric Society, 2021-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

In April 2020, the Ministry of Food and Drug Safety licensed a hexavalent combined diphtheria and tetanus toxoids and acellular pertussis (DTaP), inactivated poliovirus (IPV), Haemophilus influenzae type b (Hib) conjugated to tetanus protein, and hepatitis B (HepB) (recombinant DNA) vaccine, DTa-PIP...